Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis.

Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M.

Eur Neuropsychopharmacol. 2001 Jun;11(3):203-8.

PMID:
11418279
2.

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H.

Cytokine. 1997 Nov;9(11):853-8.

PMID:
9367546
3.

Immunological differences between patients with major depression and somatization syndrome.

Rief W, Pilger F, Ihle D, Bosmans E, Egyed B, Maes M.

Psychiatry Res. 2001 Dec 31;105(3):165-74.

PMID:
11814536
4.

Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics.

Maes M, Bocchio Chiavetto L, Bignotti S, Battisa Tura G, Pioli R, Boin F, Kenis G, Bosmans E, de Jongh R, Lin A, Racagni G, Altamura CA.

Eur Neuropsychopharmacol. 2000 Mar;10(2):119-24.

PMID:
10706993
5.

Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment.

Song C, Halbreich U, Han C, Leonard BE, Luo H.

Pharmacopsychiatry. 2009 Sep;42(5):182-8. doi: 10.1055/s-0029-1202263. Epub 2009 Sep 1.

PMID:
19724980
6.

Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.

Doganay S, Evereklioglu C, Er H, Türköz Y, Sevinç A, Mehmet N, Savli H.

Eye (Lond). 2002 Mar;16(2):163-70.

7.

Soluble interleukin-2 receptor and tumor necrosis factor levels in depressed patients in Estonia.

Eller T, Aluoja A, Maron E, Vasar V.

Medicina (Kaunas). 2009;45(12):971-7.

8.

Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.

Eller T, Vasar V, Shlik J, Maron E.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):445-50. Epub 2007 Sep 26.

PMID:
17976882
9.

Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events.

Maes M, Lin AH, Delmeire L, Van Gastel A, Kenis G, De Jongh R, Bosmans E.

Biol Psychiatry. 1999 Apr 1;45(7):833-9.

PMID:
10202570
10.

Serotonin-immune interactions in detoxified chronic alcoholic patients without apparent liver disease: activation of the inflammatory response system and lower plasma total tryptophan.

Maes M, Lin A, Bosmans E, Vandoolaeghe E, Bonaccorso S, Kenis G, De Jongh R, Verkerk R, Song C, Scharpé S, Neels H.

Psychiatry Res. 1998 May 8;78(3):151-61.

PMID:
9657419
11.

Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2.

Locker GJ, Kofler J, Stoiser B, Wilfing A, Wenzel C, Wögerbauer M, Steger GG, Zielinski CC, Mader R, Burgmann H.

Eur Cytokine Netw. 2000 Sep;11(3):391-6.

PMID:
11022123
12.

A meta-analysis of cytokines in major depression.

Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL.

Biol Psychiatry. 2010 Mar 1;67(5):446-57. doi: 10.1016/j.biopsych.2009.09.033. Epub 2009 Dec 16.

PMID:
20015486
13.

Immunological heterogeneity of multiple sclerosis in Sardinia and Sweden.

Huang YM, Liu X, Steffensen K, Sanna A, Arru G, Fois ML, Rosati G, Sotgiu S, Link H.

Mult Scler. 2005 Feb;11(1):16-23.

PMID:
15732262
14.

Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression.

Dhabhar FS, Burke HM, Epel ES, Mellon SH, Rosser R, Reus VI, Wolkowitz OM.

J Psychiatr Res. 2009 Jul;43(11):962-9. doi: 10.1016/j.jpsychires.2009.05.010. Epub 2009 Jun 23.

PMID:
19552919
15.

Activation of the inflammatory response system in autism.

Croonenberghs J, Bosmans E, Deboutte D, Kenis G, Maes M.

Neuropsychobiology. 2002;45(1):1-6.

PMID:
11803234
16.

Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression.

Yoshimura R, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Ueda N, Nakamura J.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Jun 15;33(4):722-6. doi: 10.1016/j.pnpbp.2009.03.020. Epub 2009 Mar 28.

PMID:
19332097
17.
18.
19.

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression.

Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R.

J Affect Disord. 1995 Aug 18;34(4):301-9.

PMID:
8550956
20.
Items per page

Supplemental Content

Write to the Help Desk